|
| Investment Objective
The Fund aims to achieve capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
|
|
Fund Manager:
Evan
McCulloch
/
California, United States
|
|
| Fund Base Currency: |
US dollar
|
| Fund Launch Date: |
3 April 2000
|
| Fund Size (31 December 2011): |
USD 158.6 million
|
| Fund Number: |
0796
|
| Share Class: |
A(acc)USD
|
| NAV (31 December 2011): |
USD 11.19
|
|
Date:
31 December 2011
|
Highest/Lowest NAV in Base Currency |
| Year |
Highest NAV |
Lowest NAV |
| 2011 |
11.77 |
9.45 |
|
| 2010 |
10.32 |
8.08 |
|
| 2009 |
9.05 |
7.03 |
|
| 2008 |
9.56 |
6.86 |
|
| 2007 |
9.73 |
8.32 |
|
| 2006 |
9.34 |
7.33 |
|
| 2005 |
8.69 |
6.70 |
|
| 2004 |
8.74 |
6.64 |
|
| 2003 |
7.52 |
4.85 |
|
| 2002 |
8.91 |
4.53 |
|
|
Date:
31 December 2011
|
